“High-risk Neuroblastoma in Young Adult and Long Term Survival with Multimodal Therapy: A Case Report”, IJIHS, vol. 10, no. 2, pp. 102–106, Sep. 2022, doi: 10.15850/ijihs.v10n2.2868.